Trial Profile
Enhanced passive safety surveillance of the three seasonal influenza vaccines (Influenza vaccination with Intradermal Trivalent Inactivated Influenza vaccine, Trivalent Inactivated Influenza vaccine or Quadrivalent Inactivated Influenza vaccine) during 2017/18 in Europe
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2018
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 24 Sep 2018 New trial record
- 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management